Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × neratinib × Clear all

NCT04781374 2023-07-11

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms